Fig. (2) The reduction in prescriptions, described as the decline in Defined Daily Dose (DDD) for every 1.000 of the physicians own patients for N05BA (the benzodiazepine group of anxiolytics, e.g. diazepam) for the last quarter of 2006 compared to the average DDD for the four quarters of 2003.